Magnesium in PDB 4qlq: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
All present enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8:
3.4.25.1;
Protein crystallography data
The structure of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8, PDB code: 4qlq
was solved by
G.De Bruin,
E.Huber,
B.Xin,
E.Van Rooden,
K.Al-Ayed,
K.Kim,
A.Kisselev,
C.Driessen,
G.Van Der Marel,
M.Groll,
H.Overkleeft,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
15.00 /
2.40
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
136.650,
299.590,
144.820,
90.00,
112.85,
90.00
|
R / Rfree (%)
|
19.9 /
21.5
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
(pdb code 4qlq). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the
Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8, PDB code: 4qlq:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Magnesium binding site 1 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 1 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Mg301
b:54.5
occ:1.00
|
O
|
G:MET125
|
2.3
|
45.7
|
1.0
|
O
|
G:ARG122
|
2.5
|
47.4
|
1.0
|
O
|
G:TYR119
|
2.5
|
42.1
|
1.0
|
OG1
|
G:THR8
|
2.6
|
42.3
|
1.0
|
CG2
|
G:THR8
|
3.4
|
40.5
|
1.0
|
O
|
G:ALA123
|
3.4
|
52.8
|
1.0
|
C
|
G:ARG122
|
3.5
|
46.8
|
1.0
|
C
|
G:MET125
|
3.5
|
51.5
|
1.0
|
CB
|
G:THR8
|
3.6
|
43.2
|
1.0
|
C
|
G:ALA123
|
3.6
|
50.8
|
1.0
|
CA
|
G:ALA123
|
3.6
|
47.9
|
1.0
|
C
|
G:TYR119
|
3.7
|
42.3
|
1.0
|
N
|
G:ALA123
|
4.0
|
47.2
|
1.0
|
N
|
G:MET125
|
4.1
|
50.5
|
1.0
|
CA
|
G:MET125
|
4.4
|
54.6
|
1.0
|
N
|
G:THR8
|
4.4
|
44.0
|
1.0
|
N
|
G:ARG126
|
4.4
|
51.7
|
1.0
|
CA
|
G:TYR119
|
4.4
|
41.7
|
1.0
|
CA
|
G:ARG126
|
4.5
|
47.1
|
1.0
|
N
|
G:TYR124
|
4.5
|
51.6
|
1.0
|
CA
|
G:THR8
|
4.6
|
44.2
|
1.0
|
N
|
G:ARG122
|
4.6
|
44.8
|
1.0
|
CD
|
G:PRO127
|
4.7
|
37.9
|
1.0
|
N
|
G:THR120
|
4.7
|
41.9
|
1.0
|
CA
|
G:ARG122
|
4.7
|
48.9
|
1.0
|
CB
|
G:MET125
|
4.8
|
60.3
|
1.0
|
CA
|
G:THR120
|
4.8
|
42.3
|
1.0
|
C
|
G:THR120
|
4.9
|
44.5
|
1.0
|
|
Magnesium binding site 2 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 2 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Mg301
b:69.2
occ:1.00
|
OE1
|
H:GLN91
|
2.7
|
64.3
|
1.0
|
O
|
N:HOH311
|
2.8
|
50.6
|
1.0
|
O
|
N:HOH310
|
3.1
|
50.1
|
1.0
|
O
|
N:ASN92
|
3.6
|
57.9
|
1.0
|
CD
|
H:GLN91
|
3.8
|
59.3
|
1.0
|
OD1
|
N:ASP51
|
4.0
|
49.9
|
1.0
|
OD2
|
N:ASP51
|
4.2
|
51.5
|
1.0
|
NE2
|
H:GLN91
|
4.3
|
60.1
|
1.0
|
O
|
H:HOH409
|
4.5
|
40.7
|
1.0
|
CG
|
N:ASP51
|
4.5
|
50.6
|
1.0
|
C
|
N:ASN92
|
4.7
|
54.3
|
1.0
|
|
Magnesium binding site 3 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 3 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Mg301
b:58.8
occ:1.00
|
O
|
I:ASP177
|
2.4
|
45.8
|
1.0
|
O
|
I:SER180
|
2.4
|
49.4
|
1.0
|
O
|
I:ALA174
|
2.5
|
48.1
|
1.0
|
C
|
I:ALA174
|
3.5
|
47.6
|
1.0
|
C
|
I:ASP177
|
3.6
|
45.2
|
1.0
|
C
|
I:SER180
|
3.6
|
48.3
|
1.0
|
O
|
I:HOH414
|
3.9
|
42.8
|
1.0
|
O
|
I:HOH432
|
3.9
|
50.5
|
1.0
|
CA
|
I:ASP175
|
4.0
|
47.1
|
1.0
|
N
|
I:ASP175
|
4.1
|
47.8
|
1.0
|
N
|
I:ASP177
|
4.3
|
46.1
|
1.0
|
OXT
|
I:ASP204
|
4.3
|
48.9
|
1.0
|
C
|
I:ASP175
|
4.4
|
46.0
|
1.0
|
N
|
I:SER180
|
4.4
|
47.3
|
1.0
|
CA
|
I:ASP177
|
4.5
|
45.8
|
1.0
|
N
|
I:ALA178
|
4.5
|
43.5
|
1.0
|
CA
|
I:SER180
|
4.5
|
47.5
|
1.0
|
N
|
I:GLY181
|
4.5
|
45.1
|
1.0
|
CA
|
I:ALA174
|
4.5
|
44.9
|
1.0
|
CA
|
I:ALA178
|
4.5
|
42.5
|
1.0
|
C
|
I:ALA178
|
4.6
|
44.3
|
1.0
|
O
|
I:ALA178
|
4.6
|
45.2
|
1.0
|
CA
|
I:GLY181
|
4.6
|
41.6
|
1.0
|
O
|
I:ASP175
|
4.6
|
46.2
|
1.0
|
OD1
|
I:ASP175
|
4.6
|
51.3
|
1.0
|
CB
|
I:ALA174
|
4.7
|
43.9
|
1.0
|
CB
|
I:SER180
|
4.9
|
47.9
|
1.0
|
CB
|
I:ASP177
|
5.0
|
48.4
|
1.0
|
N
|
I:ARG176
|
5.0
|
43.2
|
1.0
|
|
Magnesium binding site 4 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 4 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
K:Mg301
b:51.7
occ:1.00
|
O
|
K:ASP168
|
2.4
|
42.9
|
1.0
|
O
|
K:SER171
|
2.4
|
52.6
|
1.0
|
O
|
W:ASP204
|
2.4
|
56.9
|
1.0
|
O
|
K:ALA165
|
2.5
|
45.2
|
1.0
|
C
|
W:ASP204
|
3.2
|
51.8
|
1.0
|
C
|
K:ASP168
|
3.4
|
41.1
|
1.0
|
NH1
|
K:ARG19
|
3.6
|
50.4
|
1.0
|
C
|
K:SER171
|
3.6
|
51.3
|
1.0
|
C
|
K:ALA165
|
3.6
|
46.3
|
1.0
|
CA
|
W:ASP204
|
3.7
|
47.7
|
1.0
|
CA
|
K:ALA169
|
3.8
|
38.1
|
1.0
|
C
|
K:ALA169
|
3.9
|
43.0
|
1.0
|
O
|
K:ALA169
|
3.9
|
45.2
|
1.0
|
N
|
K:ALA169
|
4.0
|
39.5
|
1.0
|
OXT
|
W:ASP204
|
4.0
|
53.7
|
1.0
|
CB
|
W:ASP204
|
4.0
|
46.5
|
1.0
|
N
|
K:SER171
|
4.1
|
51.2
|
1.0
|
CZ
|
K:ARG19
|
4.3
|
52.0
|
1.0
|
CA
|
K:ALA165
|
4.4
|
45.8
|
1.0
|
O
|
K:HIS166
|
4.4
|
42.0
|
1.0
|
CA
|
K:SER171
|
4.4
|
49.4
|
1.0
|
NH2
|
K:ARG19
|
4.5
|
56.0
|
1.0
|
CA
|
K:ASP168
|
4.6
|
39.7
|
1.0
|
N
|
K:ASP168
|
4.6
|
39.7
|
1.0
|
N
|
K:TYR170
|
4.6
|
46.2
|
1.0
|
C
|
K:HIS166
|
4.6
|
42.4
|
1.0
|
N
|
K:GLY172
|
4.6
|
50.2
|
1.0
|
N
|
K:HIS166
|
4.6
|
43.5
|
1.0
|
CA
|
K:GLY172
|
4.7
|
49.8
|
1.0
|
O
|
K:ALA164
|
4.7
|
46.0
|
1.0
|
CA
|
K:HIS166
|
4.8
|
42.6
|
1.0
|
CB
|
K:SER171
|
4.9
|
46.1
|
1.0
|
CG
|
W:ASP204
|
5.0
|
49.6
|
1.0
|
|
Magnesium binding site 5 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 5 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
N:Mg201
b:48.4
occ:1.00
|
O
|
N:ILE163
|
2.5
|
48.0
|
1.0
|
O
|
N:SER169
|
2.7
|
54.7
|
1.0
|
O
|
N:ASP166
|
2.9
|
49.8
|
1.0
|
CD1
|
a:LEU34
|
3.5
|
46.3
|
1.0
|
NH1
|
N:ARG19
|
3.6
|
54.2
|
1.0
|
C
|
N:ILE163
|
3.7
|
53.5
|
1.0
|
C
|
N:SER169
|
3.8
|
51.6
|
1.0
|
C
|
N:ASP166
|
3.9
|
47.5
|
1.0
|
CG2
|
N:ILE163
|
4.0
|
46.6
|
1.0
|
CA
|
N:GLY167
|
4.2
|
44.4
|
1.0
|
CA
|
N:ILE163
|
4.3
|
53.2
|
1.0
|
CZ
|
N:ARG19
|
4.4
|
55.9
|
1.0
|
O
|
N:GLY167
|
4.4
|
47.0
|
1.0
|
CA
|
N:GLY170
|
4.5
|
54.8
|
1.0
|
N
|
N:GLY167
|
4.5
|
45.7
|
1.0
|
C
|
N:GLY167
|
4.5
|
44.8
|
1.0
|
N
|
N:GLY170
|
4.6
|
51.2
|
1.0
|
NH2
|
N:ARG19
|
4.7
|
50.5
|
1.0
|
N
|
N:LYS164
|
4.8
|
56.0
|
1.0
|
N
|
N:SER169
|
4.8
|
46.0
|
1.0
|
CB
|
N:ILE163
|
4.8
|
50.2
|
1.0
|
CA
|
N:SER169
|
4.8
|
47.0
|
1.0
|
CG
|
a:LEU34
|
4.9
|
47.0
|
1.0
|
O
|
N:LYS164
|
4.9
|
53.8
|
1.0
|
C
|
N:LYS164
|
4.9
|
57.7
|
1.0
|
CA
|
N:LYS164
|
5.0
|
59.7
|
1.0
|
|
Magnesium binding site 6 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 6 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
V:Mg301
b:54.8
occ:1.00
|
O
|
V:ASP166
|
2.2
|
47.6
|
1.0
|
O
|
V:SER169
|
2.2
|
49.0
|
1.0
|
OXT
|
L:ASP222
|
2.2
|
48.1
|
1.0
|
O
|
V:ILE163
|
2.3
|
45.6
|
1.0
|
C
|
L:ASP222
|
3.1
|
55.4
|
1.0
|
C
|
V:ASP166
|
3.1
|
44.1
|
1.0
|
C
|
V:ILE163
|
3.4
|
47.8
|
1.0
|
C
|
V:SER169
|
3.4
|
50.6
|
1.0
|
CA
|
L:ASP222
|
3.8
|
52.6
|
1.0
|
CA
|
V:LEU167
|
3.8
|
44.5
|
1.0
|
O
|
V:GLY162
|
3.8
|
45.6
|
1.0
|
N
|
V:LEU167
|
3.8
|
45.3
|
1.0
|
NH1
|
V:ARG19
|
3.9
|
44.0
|
1.0
|
O
|
L:ASP222
|
3.9
|
62.7
|
1.0
|
N
|
V:ASP166
|
4.0
|
49.5
|
1.0
|
CA
|
V:ILE163
|
4.1
|
49.6
|
1.0
|
N
|
V:SER169
|
4.1
|
43.7
|
1.0
|
CA
|
V:ASP166
|
4.2
|
44.7
|
1.0
|
CB
|
L:ASP222
|
4.2
|
46.5
|
1.0
|
C
|
V:LEU167
|
4.2
|
43.4
|
1.0
|
CA
|
V:SER169
|
4.3
|
47.3
|
1.0
|
N
|
V:TRP164
|
4.3
|
46.2
|
1.0
|
C
|
V:TRP164
|
4.3
|
52.6
|
1.0
|
N
|
V:GLY170
|
4.3
|
52.8
|
1.0
|
CZ
|
V:ARG19
|
4.4
|
46.2
|
1.0
|
CA
|
V:GLY170
|
4.4
|
53.2
|
1.0
|
O
|
V:TRP164
|
4.4
|
53.6
|
1.0
|
NH2
|
V:ARG19
|
4.5
|
48.7
|
1.0
|
CA
|
V:TRP164
|
4.5
|
48.3
|
1.0
|
O
|
V:LEU167
|
4.6
|
44.3
|
1.0
|
N
|
V:ASN165
|
4.6
|
53.5
|
1.0
|
CB
|
V:SER169
|
4.7
|
47.5
|
1.0
|
C
|
V:GLY162
|
4.8
|
45.5
|
1.0
|
C
|
V:ASN165
|
4.8
|
50.9
|
1.0
|
N
|
V:GLY168
|
4.8
|
40.5
|
1.0
|
CB
|
V:ASP166
|
4.9
|
43.4
|
1.0
|
N
|
V:ILE163
|
5.0
|
45.8
|
1.0
|
CD2
|
V:LEU167
|
5.0
|
45.4
|
1.0
|
|
Magnesium binding site 7 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 7 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Y:Mg301
b:49.5
occ:1.00
|
O
|
Y:ASP168
|
2.3
|
41.3
|
1.0
|
O
|
Y:SER171
|
2.3
|
51.7
|
1.0
|
O
|
Y:HOH408
|
2.4
|
44.5
|
1.0
|
O
|
Y:ALA165
|
2.4
|
42.8
|
1.0
|
O
|
I:ASP204
|
2.5
|
63.2
|
1.0
|
C
|
I:ASP204
|
3.3
|
49.8
|
1.0
|
C
|
Y:ASP168
|
3.3
|
39.1
|
1.0
|
C
|
Y:SER171
|
3.5
|
49.2
|
1.0
|
C
|
Y:ALA165
|
3.5
|
42.3
|
1.0
|
NH1
|
Y:ARG19
|
3.6
|
63.8
|
1.0
|
CA
|
I:ASP204
|
3.8
|
49.1
|
1.0
|
CA
|
Y:ALA169
|
3.8
|
40.6
|
1.0
|
C
|
Y:ALA169
|
3.9
|
40.9
|
1.0
|
N
|
Y:ALA169
|
3.9
|
39.5
|
1.0
|
O
|
Y:ALA169
|
4.0
|
39.8
|
1.0
|
N
|
Y:SER171
|
4.0
|
45.2
|
1.0
|
CB
|
I:ASP204
|
4.0
|
46.5
|
1.0
|
OXT
|
I:ASP204
|
4.1
|
48.9
|
1.0
|
CA
|
Y:ALA165
|
4.2
|
41.5
|
1.0
|
CZ
|
Y:ARG19
|
4.3
|
61.5
|
1.0
|
CA
|
Y:SER171
|
4.3
|
45.6
|
1.0
|
O
|
Y:HIS166
|
4.4
|
41.5
|
1.0
|
CA
|
Y:ASP168
|
4.5
|
37.4
|
1.0
|
N
|
Y:ASP168
|
4.5
|
40.2
|
1.0
|
N
|
Y:GLY172
|
4.5
|
47.9
|
1.0
|
N
|
Y:TYR170
|
4.5
|
43.2
|
1.0
|
N
|
Y:HIS166
|
4.6
|
41.1
|
1.0
|
C
|
Y:HIS166
|
4.6
|
41.2
|
1.0
|
NH2
|
Y:ARG19
|
4.6
|
65.2
|
1.0
|
O
|
Y:ALA164
|
4.6
|
42.4
|
1.0
|
CA
|
Y:GLY172
|
4.6
|
46.1
|
1.0
|
CA
|
Y:HIS166
|
4.8
|
39.4
|
1.0
|
CB
|
Y:SER171
|
4.8
|
46.0
|
1.0
|
|
Magnesium binding site 8 out
of 8 in 4qlq
Go back to
Magnesium Binding Sites List in 4qlq
Magnesium binding site 8 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 8 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Z:Mg301
b:57.9
occ:1.00
|
O
|
Z:THR192
|
2.6
|
45.3
|
1.0
|
O
|
Z:VAL198
|
2.6
|
53.5
|
1.0
|
O
|
Z:HIS195
|
2.8
|
43.9
|
1.0
|
C
|
Z:THR192
|
3.6
|
46.5
|
1.0
|
CG2
|
Z:THR192
|
3.7
|
37.3
|
1.0
|
C
|
Z:HIS195
|
3.8
|
42.2
|
1.0
|
C
|
Z:VAL198
|
3.8
|
52.5
|
1.0
|
NH2
|
Z:ARG28
|
3.9
|
52.1
|
1.0
|
CA
|
Z:THR192
|
3.9
|
44.4
|
1.0
|
CA
|
Z:ILE196
|
4.0
|
39.8
|
1.0
|
O
|
Z:ASP222
|
4.0
|
53.5
|
1.0
|
O
|
Z:ILE196
|
4.1
|
41.3
|
1.0
|
C
|
Z:ILE196
|
4.2
|
40.9
|
1.0
|
N
|
Z:ILE196
|
4.3
|
39.4
|
1.0
|
NH2
|
H:ARG19
|
4.4
|
52.7
|
1.0
|
N
|
Z:VAL198
|
4.5
|
49.6
|
1.0
|
CB
|
Z:THR192
|
4.5
|
40.8
|
1.0
|
OD1
|
Z:ASP222
|
4.5
|
51.4
|
1.0
|
CA
|
Z:VAL198
|
4.7
|
51.1
|
1.0
|
N
|
Z:GLY199
|
4.7
|
50.2
|
1.0
|
N
|
Z:HIS195
|
4.8
|
44.5
|
1.0
|
N
|
Z:GLU193
|
4.8
|
47.2
|
1.0
|
CA
|
Z:GLY199
|
4.8
|
50.2
|
1.0
|
C
|
Z:ASP222
|
4.9
|
52.0
|
1.0
|
CA
|
Z:HIS195
|
4.9
|
43.4
|
1.0
|
O
|
Z:ALA191
|
5.0
|
43.2
|
1.0
|
N
|
Z:GLN197
|
5.0
|
43.0
|
1.0
|
CZ
|
Z:ARG28
|
5.0
|
53.0
|
1.0
|
|
Reference:
G.De Bruin,
E.M.Huber,
B.T.Xin,
E.J.Van Rooden,
K.Al-Ayed,
K.B.Kim,
A.F.Kisselev,
C.Driessen,
M.Van Der Stelt,
G.A.Van Der Marel,
M.Groll,
H.S.Overkleeft.
Structure-Based Design of Beta 1I or Beta 5I Specific Inhibitors of Human Immunoproteasomes J.Med.Chem. V. 57 6197 2014.
ISSN: ISSN 0022-2623
PubMed: 25006746
DOI: 10.1021/JM500716S
Page generated: Tue Aug 20 02:03:16 2024
|